BMC Pulmonary Medicine最新文献

{"title":"Maximizing phonation: impact of inspiratory muscle strengthening on vocal durations and pitch range.","authors":"Coşkun Yilmaz, Özgür Bostanci, Özgür Eken, Rania Alkahtani, Monira I Aldhahi","doi":"10.1186/s12890-024-03471-2","DOIUrl":"10.1186/s12890-024-03471-2","url":null,"abstract":"<p><strong>Background: </strong>This study investigated the acute effects of inspiratory muscle warm-up (IWU) on vocal performance in singers. Proper vocal and respiratory warm-up can enhance vocal range, quality, and endurance. The aim was to determine whether IWU improves maximum phonation time and pitch range, contributing to better voice production efficiency (vocal efficiency) and reduced fatigue.</p><p><strong>Materials and methods: </strong>Singers were selected from the Samsun State Opera and the Ballet Directorate (n = 16). This cross-sectional study aimed to investigate the acute effects. The singers in the control group (SC = 8) performed only one session of routine voice warm-up, and the experimental group (SE = 8) conducted an inspiratory muscle warm-up (IWU) of 2 sets, 30 times/set at 40% maximal inspiratory pressure (MIP) in addition to routine voice warm-up. Subsequently, All participants were then required to perform pre- and post- pulmonary function tests, maximal inspiratory pressure (MIP) and maximal expiratory pressure (MEP), and voice recordings (note high pitch, note low pitch, high pitch durations and low pitch durations sustained with one breath, and maximum phonation duration).</p><p><strong>Results: </strong>All pulmonary function and muscle strength parameters improved in the SE group, with the highest increases in MIP (22.9%) and MEP (14.7%). No significant improvements were noted in the SC group (p > 0.05). The Borg Rating of Perceived Exertion showed that the SE group experienced less difficulty with their vocal performance after IWU (-11.6%, p = 0.006), while no significant change was observed in the SC group (p = 0.316). Both warm-up methods used in the study significantly affected the frequencies of high-pitch sounds (SE = 17.8%, SC = 10.9%, p = 0.003); however, the frequency of low-pitch sounds was not significantly affected (p = 0.437). IWU significantly affected the high-pitched note duration (p < 0.001; 32.17%), low-pitched note duration (p < 0.001; 27.11%), and maximum phonation time (p < 0.001; 21%), while routine voice warm-up did not significantly affect any parameter (p > 0.05).</p><p><strong>Conclusions: </strong>The combination of IWU with the general body and voice warm-up protocol can acutely improve vocal performance in terms of maximum phonation time, phonation times of the highest and lowest pitched sounds in a single breath, and vocal range levels.</p>","PeriodicalId":9148,"journal":{"name":"BMC Pulmonary Medicine","volume":"25 1","pages":"15"},"PeriodicalIF":2.6,"publicationDate":"2025-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11725213/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142968826","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Biological characterization and clinical significance of cuproptosis-related genes in lung adenocarcinoma.","authors":"Meilin Li, Yu Tan, Zhixin Li, Lingfeng Min","doi":"10.1186/s12890-025-03477-4","DOIUrl":"10.1186/s12890-025-03477-4","url":null,"abstract":"<p><strong>Background: </strong>Lung cancer has high morbidity and mortality rates, which results in a poor prognosis. Cuproptosis is a novel cell death mechanism. The aim of this study was to examine the biological characteristics and clinical significance of genes associated with cuproptosis in lung adenocarcinoma (LUAD), and to understand the molecular mechanisms underlying the occurrence and progression of LUAD.</p><p><strong>Methods: </strong>We targeted 10 cuproptosis-related genes from previous studies and used the datasets from GEO and TCGA databases to identify differential genes related to cuproptosis; then the data were analyzed by R package, Cytoscape, TISDB, cBioPortal, STRING, CancerSEA, and Disgenet; and finally, the data were detected by immunohistochemistry validation was performed.</p><p><strong>Results: </strong>CDKN2A and MTF1 were cuproptosis-associated LUAD differential genes and were differentially expressed in immune subtypes. The expression of CDKN2A and MTF1 showed correlation with multiple functional states of LUAD.CDKN2A was negatively correlated with LUAD survival prognosis.</p><p><strong>Conclusion: </strong>CDKN2A and MTF1 were correlated with the diagnosis of LUAD, and CDKN2A was negatively correlated with the survival and prognosis of LUAD. CDKN2A has the potential to contribute to the early diagnosis and prognosis analysis of LUAD.</p>","PeriodicalId":9148,"journal":{"name":"BMC Pulmonary Medicine","volume":"25 1","pages":"13"},"PeriodicalIF":2.6,"publicationDate":"2025-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11725195/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142969651","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Comprehensive analysis pinpoints CCNA2 as a prognostic and immunological biomarker in non-small cell lung cancer.","authors":"Liming Zhang, Shaoqiang Wang, Lina Wang","doi":"10.1186/s12890-025-03490-7","DOIUrl":"10.1186/s12890-025-03490-7","url":null,"abstract":"<p><strong>Background: </strong>Lung cancer is a leading cause of morbidity and mortality globally. Despite advances in targeted and immunotherapies, overall survival (OS) rates remain suboptimal. Cyclin-A2 (CCNA2), known for its upregulation in various tumors and role in tumorigenesis, has an undefined function in non-small cell lung cancer (NSCLC).</p><p><strong>Methods: </strong>We analyzed three microarray datasets from the Gene Expression Omnibus (GEO) repository to identify differentially expressed genes. Using STRING, we constructed a protein-protein interaction (PPI) network to pinpoint hub genes. The expression and prognostic relevance of CCNA2 were validated using GEPIA and the Kaplan-Meier plotter. Clinicopathological correlations were assessed via the Human Protein Atlas (HPA) and UALCAN databases. qRT-PCR and immunohistochemistry (IHC) were performed to validate CCNA2 mRNA and protein levels. Loss-of-function assays in lung cancer cell lines evaluated the biological role of CCNA2. Immune infiltration and single-cell sequencing were also explored.</p><p><strong>Results: </strong>Analysis of GSE18842, GSE101929, and GSE116959 datasets identified 321 upregulated and 623 downregulated genes in NSCLC. CCNA2 was confirmed to be highly expressed in NSCLC through qRT-PCR and IHC, with overexpression correlating with advanced pathological stages and lymph node metastasis. The area under the curve (AUC) of CCNA2 indicating high diagnostic accuracy. Immune infiltration and single-cell sequencing revealed that CCNA2 expression was significantly associated with immune cell infiltration, particularly in Tprolif cells.</p><p><strong>Conclusion: </strong>CCNA2 is upregulated in NSCLC and shows significant correlation with clinicopathological characteristics. Our findings suggest that CCNA2 may serve as a promising biomarker for both the prognosis and diagnosis of NSCLC.</p>","PeriodicalId":9148,"journal":{"name":"BMC Pulmonary Medicine","volume":"25 1","pages":"14"},"PeriodicalIF":2.6,"publicationDate":"2025-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11725219/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142969652","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Metagenomic analysis identifying a polymicrobial pulmonary infection in a non-HIV immunocompromised patient: a case report.","authors":"Jing Duan, Jie Ding, Yupeng Wei, Yingxin Zhang, Zhiqing You, Ding Li, Chao Chen","doi":"10.1186/s12890-024-03473-0","DOIUrl":"10.1186/s12890-024-03473-0","url":null,"abstract":"<p><strong>Background: </strong>Polymicrobial pulmonary infections, common in immunocompromised patients, often manifest more severe symptoms than monomicrobial infections. Clinical diagnosis delays may lead to mortality, emphasizing the importance of fast and accurate diagnosis for these patients. Metagenomic next-generation sequencing (mNGS), as an unbiased method capable of detecting all microbes, is a valuable tool to identify pathogens, particularly in cases where infections are difficult to diagnosis using conventional methods.</p><p><strong>Case presentation: </strong>A 50-year-old male patient was admitted due to cough, expectoration and dyspnea. CT scan revealed diffuse inflammatory and cavernous lung lesion, and blood examination suggested a polymicrobial infection. However, no etiology was found by routine examination. mNGS of bronchoalveolar lavage fluid(BALF)simultaneously detected the presence of Pneumocystis jirovecii (P.jirovecii), Aspergillus fumigates (A.fumigates), Nocardia farcinica (N.farcinica), Salmonella enterica subsp. enterica (S.enterica subsp. enterica), and cytomegalovirus (CMV). The patient was successfully treated with compound sulfamethoxazole (SMZ-TMP), cefoperazone/sulbactam (SCF), moxifloxacin (MXF), voriconazole (VCZ), and ganciclovir. The patient recovered after two weeks of anti-infection therapy and maintained good health at a six-month follow-up.</p><p><strong>Conclusion: </strong>For immunocompromised patients with multiple infections and atypical symptoms, mNGS emerged as a reliable approach to pathogen detection and guiding antibiotic therapy.</p>","PeriodicalId":9148,"journal":{"name":"BMC Pulmonary Medicine","volume":"25 1","pages":"12"},"PeriodicalIF":2.6,"publicationDate":"2025-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11720941/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142944663","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Lung ultrasound for assessing disease progression in UIP and NSIP: a comparative study with HRCT and PFT/DLCO.","authors":"Nasrollahzadeh Milad, Idani Esmaeil, Abedini Atefeh, Malekshoaar Mehran, Sadeghi Mohsen, Kasravi Maryam, Tofighi Rozhin, Roostaei Ghazal, Kiani Arda","doi":"10.1186/s12890-024-03433-8","DOIUrl":"10.1186/s12890-024-03433-8","url":null,"abstract":"<p><strong>Background: </strong>This study aims to compare Lung Ultrasound (LUS) findings with High-Resolution Computerized Tomography (HRCT) and Pulmonary Function Tests (PFTs) to detect the severity of lung involvement in patients with Usual Interstitial Pneumonia (UIP) and Non-Specific Interstitial Pneumonia (NSIP).</p><p><strong>Methods: </strong>A cross-sectional study was conducted on 35 UIP and 30 NSIP patients at a referral hospital. All patients underwent LUS, HRCT, and PFT. LUS findings such as B-lines, pleural fragmentation, and pleural thickening were compared with HRCT-based lung involvement and PFT parameters.</p><p><strong>Results: </strong>In UIP patients, B-lines > 18 and pleural fragmentation significantly differentiated between < 50% and > 50% HRCT involvement. A logistic regression model showed that B-lines > 18 (OR = 39, p = 0.04) and pleural fragmentation (OR = 22, p = 0.037) independently predicted > 50% HRCT involvement. ROC analysis of the model revealed 84.2% sensitivity and 84.5% specificity. Furthermore, the crude number of B-lines (OR = 1.2, p = 0.038) and > 50% HRCT involvement (OR = 9.5, p = 0.045) independently predicted severe DLCO impairment, with a sensitivity of 94.7% and specificity of 84.5%. Linear regression showed that each additional B-line was associated with a 0.4% decrease in DLCO (Beta = -0.377, p = 0.043), independent of patient diagnosis. In NSIP patients, no significant correlation was observed between LUS findings and > 50% HRCT involvement (p > 0.05), though B-line numbers and pleural thickening increased in cases with severe DLCO impairment (p < 0.05).</p><p><strong>Conclusions: </strong>LUS shows promise as a sensitive, radiation-free alternative to HRCT in monitoring the severity of UIP. It is particularly valuable in predicting the extent of lung involvement and severe DLCO impairment in UIP patients but has limited application in NSIP.</p>","PeriodicalId":9148,"journal":{"name":"BMC Pulmonary Medicine","volume":"25 1","pages":"11"},"PeriodicalIF":2.6,"publicationDate":"2025-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11716402/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142944716","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Iatrogenic intramural esophageal hematoma during EUS-B-FNA procedure.","authors":"João Oliveira Rodrigues, Paulo Matos, Luís Vaz Rodrigues, Michele de Santis, Lourdes Barradas","doi":"10.1186/s12890-024-03470-3","DOIUrl":"10.1186/s12890-024-03470-3","url":null,"abstract":"<p><strong>Background: </strong>Esophageal ultrasound with bronchoscope fine needle aspiration (EUS-B-FNA) is a valuable tool for the diagnosis and staging of lung cancer, complementing endobronchial lung ultrasound (EBUS). While generally considered safe, there is a notable lack of comprehensive knowledge within the interventional pulmonology community regarding potential complications.</p><p><strong>Case presentation: </strong>We present a case involving a 66-year-old male with squamous cell lung carcinoma undergoing mediastinal staging. A systematic mediastinal assessment through EBUS confirmed the presence of enlarged lymph nodes at 4 L with limited access to puncture. Complementary EUS-B widened the visualization and access to station 4 L and after excluding nearby vessels, a single puncture was performed. Unexpectedly, an iatrogenic esophageal hematoma was promptly noted at the puncture site. The procedure was immediately interrupted, and subsequent workup confirmed the hematoma without active bleeding. Conservative management, including upper endoscopy and clip sealing, resulted in the patient's asymptomatic recovery.</p><p><strong>Conclusion: </strong>This case underscores the importance of recognizing and managing complications associated with EUS-B-FNA, emphasizing the need for heightened awareness and education in the interventional pulmonology community. Despite being infrequently discussed in medical literature, EUS-B-FNA can give rise to both immediate and delayed complications, warranting increased vigilance during its practice.</p>","PeriodicalId":9148,"journal":{"name":"BMC Pulmonary Medicine","volume":"25 1","pages":"10"},"PeriodicalIF":2.6,"publicationDate":"2025-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11715552/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142944712","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Carboplatin in combination with etoposide for advanced small cell lung cancer complicated with idiopathic interstitial pneumonia: a single-arm phase II study.","authors":"Masaru Matsumoto, Yuji Minegishi, Katsuyuki Higa, Aya Fukuizumi, Naomi Onda, Susumu Takeuchi, Akihiko Miyanaga, Akihiko Gemma, Masahiro Seike","doi":"10.1186/s12890-024-03459-y","DOIUrl":"10.1186/s12890-024-03459-y","url":null,"abstract":"<p><strong>Background: </strong>Acute exacerbation (AEx) of interstitial pneumonia is the most common lethal adverse event related to the pharmacological treatment of patients with lung cancer complicated with interstitial pneumonia. Although small cell lung cancer (SCLC) is linked to poor prognosis, it exhibits good response to chemotherapy. Few previous research studies have investigated the safety and efficacy of treatment for advanced SCLC complicated with idiopathic interstitial pneumonia (IIP). We conducted a single-arm phase II study to evaluate the safety and efficacy of carboplatin plus etoposide for the treatment of patients with SCLC complicated with IIP.</p><p><strong>Methods: </strong>Chemotherapy-naïve patients with advanced SCLC complicated with IIP were enrolled. Patients received carboplatin every 21-28 days at a dose of area under the curve 4-6 on day 1 and etoposide at a dose of 80-100 mg/m² on days 1-3.</p><p><strong>Results: </strong>Thirty-one patients were enrolled between December 2009 and December 2022. A median of four cycles of carboplatin plus etoposide were administered. Acute exacerbation of idiopathic interstitial pneumonia was not observed; the rate of AEx was 0% (95% confidence interval [CI]: 0-9.6%, p = 0.038). The objective response rate was 83.9% (95% CI: 82.5-85.2). The median progression-free survival and overall survival were 5.9 (95% CI: 4.7-6.8) months and 14.0 (95% CI: 7.6-27.6) months, respectively. The 1-year survival rate was 61% (95% CI 41-76).</p><p><strong>Conclusions: </strong>The carboplatin plus etoposide treatment was tolerable and effective in SCLC patients complicated with IIP.</p>","PeriodicalId":9148,"journal":{"name":"BMC Pulmonary Medicine","volume":"25 1","pages":"9"},"PeriodicalIF":2.6,"publicationDate":"2025-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11707951/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142944706","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Primary bronchial leiomyosarcoma: a diagnostic challenge.","authors":"Dan Chen, Shuai Luo","doi":"10.1186/s12890-024-03472-1","DOIUrl":"10.1186/s12890-024-03472-1","url":null,"abstract":"<p><strong>Background: </strong>Pulmonary bronchial leiomyosarcoma is an extremely rare malignant tumour of the lung originating from the mesenchymal tissue. The retroperitoneal region is the most common site of leiomyosarcoma. It exhibits a high degree of malignancy and a poor prognosis, thereby highlighting the significance of early diagnosis of this disease.</p><p><strong>Case demonstration: </strong>A 61-year-old male with a smoking history of 40 + years was admitted to the hospital due to cough, expectoration, and shortness of breath that extended for half a year, which aggravated for two months and was succeeded by intermittent bloody sputum for one month. Chest computed tomography (CT) revealed a mass in the upper lobe of the right lung, which was identified as a malignant tumour lesion involving the upper thoracic oesophagus. The boundaries of the mass with the trachea, brachiocephalic artery, and right brachiocephalic vein were unclear. Brush liquid-based cytology of the right middle lobe bronchus was performed, followed by histopathological biopsy. The pathological diagnosis was leiomyosarcoma in the middle lobe of the right lung. After the diagnosis, he underwent chemotherapy in another hospital, and the case was followed up for six months, during which no recurrence was noted.</p><p><strong>Conclusions: </strong>Pulmonary and bronchial leiomyosarcomas often occur in young males with rapid progression and poor prognosis, but metastasis is rare. Surgical resection is the first-line treatment. We report a case of pulmonary bronchial leiomyosarcoma. The cytological, histological, immunohistochemical, and differential diagnoses were analysed to improve the understanding of the disease. Presently, there exist some challenges in diagnosing and treating pulmonary bronchial leiomyosarcoma. Early detection and treatment are important to improve prognosis.</p>","PeriodicalId":9148,"journal":{"name":"BMC Pulmonary Medicine","volume":"25 1","pages":"8"},"PeriodicalIF":2.6,"publicationDate":"2025-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11707924/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142944668","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Association between lipid accumulation product and chronic obstructive pulmonary disease: a cross-sectional analysis.","authors":"Shaofeng Zhang, Zhongli Li, Yaling Zeng, Jia Jiang, Wei Lei, Siqin Chen, Jiayi Liu, Jia Li, Xin Chen, Qiang Xiao","doi":"10.1186/s12890-024-03465-0","DOIUrl":"https://doi.org/10.1186/s12890-024-03465-0","url":null,"abstract":"<p><strong>Background: </strong>Research indicates that obesity can worsen the clinical manifestations of chronic obstructive pulmonary disease (COPD). Timely detection of COPD has the potential to enhance treatment results. This study seeks to investigate the association between a new metabolic indicator, the lipid accumulation product (LAP), and the risk of developing COPD.</p><p><strong>Methods: </strong>The observational analysis employs data from the National Health and Nutrition Examination Survey (NHANES) conducted from 2007 to 2016. Multivariate logistic regression was used to explore the association between LAP levels and COPD. Further analysis methods included subgroup analysis, smooth curve modeling, and threshold effect evaluation.</p><p><strong>Results: </strong>Within the sample of 12,089 individuals, 1,072 were diagnosed with COPD. A positive correlation between LAP levels and COPD risk was identified through logistic regression analysis, even after controlling for potential confounders. The analyses by subgroup showed an enhanced association in participants without hypertension. The smooth curve fitting analysis highlighted particular saturation effects of LAP, with significant inflection points identified at 65.5278 and a P-value of 0.013.</p><p><strong>Conclusion: </strong>This study's findings suggest that elevated LAP levels are associated with an increased risk of COPD. It is suggested that dietary modifications and exercise routines be implemented to mitigate COPD risk in those with higher LAP levels.</p>","PeriodicalId":9148,"journal":{"name":"BMC Pulmonary Medicine","volume":"25 1","pages":"6"},"PeriodicalIF":2.6,"publicationDate":"2025-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11702100/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142944697","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Correction: The predictive effects of adiponectin and irisin hormones on diagnosis and clinical involvement of Sarcoidosis.","authors":"Huseyin Kaya, Hasim Boyaci, Serap Argun Baris, Ilknur Basyigit, Ozgur Doga Ozsoy, Hale Maral Kir","doi":"10.1186/s12890-024-03467-y","DOIUrl":"https://doi.org/10.1186/s12890-024-03467-y","url":null,"abstract":"","PeriodicalId":9148,"journal":{"name":"BMC Pulmonary Medicine","volume":"25 1","pages":"7"},"PeriodicalIF":2.6,"publicationDate":"2025-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11706004/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142944709","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}